Three Indian Americans among 21 selected by Aspen Institute for Health Innovators Fellowship

Dipal Doshi, Sachin Jain and Rupal Patel make the cut.

AB Wire

aspen institute

Three Indian Americans – Dipal Doshi, Sachin Jain and Rupal Patel –are among 21 individuals selected by the Aspen Institute for its Health Innovators Fellowship.

The Aspen Institute launched the Fellowship in 2015 in partnership with the Greenville Health System, South Carolina’s largest not-for-profit healthcare system and an advocate for healthy living initiatives across the state.

“The Health Innovators Fellowship challenges leaders to create meaningful change in health care,” said Michael C. Riordan, president and CEO of Greenville Health System, in a press release. “As an academic health center with a vision to transform healthcare, we are excited to partner with the Aspen Institute and witness the power of the Fellows’ collective ability to innovate care.”

The Health Innovator Fellows will spend four weeks over the course of two years exploring their leadership, core values, desired legacies, and their vision for the health care system. Each Fellow commits to launching a leadership venture that will stretch and challenge them and have a positive impact on health care in the U.S. The Health Innovator Fellows join more than 2,200 other entrepreneurial leaders from 49 countries to become members of the Aspen Global Leadership Network.

Dipal Doshi is Chief Business Officer, Amicus Therapeutics, Inc. Princeton, New Jersey. He is also the general manager of Scioderm, Inc., a rare disease company Amicus acquired in 2015. Prior to joining Amicus, Doshi founded RStreet Advisors, a healthcare consulting firm through which he advised pharmaceutical, biotech, and diagnostics companies on business development, corporate strategy, and market and commercial planning.

From 2008 to 2013, Doshi was the senior vice president and member of the management team at Auven Therapeutics, a global private equity and bio-pharmaceutical development company. He led or participated in the operations and financing of several biotech and pharmaceutical companies and was an Observer on the Board of Directors of Spirogen (acquired by AstraZeneca in 2013) and ADC Therapeutics.

From 2005 to 2008, Doshi was the head of corporate development for Catalent Pharma Solutions and also held interim operating roles in the biotechnology, inhalation, and analytical tools practices. Prior to Catalent, he was a member of Merrill Lynch’s Investment Banking Group. During his tenure at Eli Lilly, he was a member of both the strategic marketing team and Lilly Ventures where he developed and led a portfolio company. He was also a sales representative in New York. As a consultant for both Mercer Management Consulting (Oliver Wyman) and Sapient Corporation (Publicis), he advised healthcare, consumer, and technology companies.  He received a B.A. from Rutgers University and an MBA from The Wharton School of the University of Pennsylvania. He is a Fellow of the second class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

Sachin Jain, MD President and CEO, CareMore Los Angeles, California, an innovative health plan & care delivery system with $1.2 billion in revenue and over 100,000 members in eight states. He is also a consulting professor of medicine at the Stanford University School of Medicine and a contributor at Forbes.

Dr. Jain was previously CareMore’s chief medical officer and chief operating officer. Prior to joining CareMore, Dr. Jain was chief medical information & innovation officer at Merck & Co. He also served as an attending physician at the Boston VA-Boston Medical Center and was on faculty at Harvard Medical School and Harvard Business School. From 2009-2011, Dr. Jain worked in the Obama Administration, where he was senior advisor to Donald Berwick when he led the Centers for Medicare & Medicaid Services (CMS).

Dr. Jain was the first deputy director for policy and programs at the Center for Medicare and Medicaid Innovation, and he was special assistant to David Blumenthal when he was the National Coordinator for Health Information Technology. Dr. Jain graduated magna cum laude from Harvard College with a bachelor’s degree in government and earned his MD from Harvard Medical School and MBA from Harvard Business School. He trained in medicine at the Brigham and Women’s Hospital, earned his board certification from the American Board of Internal Medicine, and continues to practice medicine at CareMore. He is co-founder and co-editor-in-chief of the Elsevier journal Healthcare: The Journal of Delivery Science & Innovation and is an elected member of the National Academy of Social Insurance. He has published over 100 peer-reviewed articles and in journals such as the New England Journal, JAMA, Health Affairs, and the Harvard Business Review blogs, and he was an editor of the book, The Soul of a Doctor (Algonquin Press). Dr. Jain is a native of Bergen County, New Jersey, but presently resides in Los Angeles, California.

Rupal Patel, PhD Founder & CEO, VocaliD Inc. Boston, Massachusetts, a speech technology company that creates custom voices for text-to-speech applications, leveraging its crowd sourced Human Voicebank.

VocaliD’s award-winning technology has been featured on TED and NPR and in leading news and technology outlets such as The Wall Street Journal, Wired, Bloomberg, and BuzzFeed. She is currently on leave from Northeastern University where she is a tenured professor in the College of Computer and Information Science and the Department of Communication Sciences and Disorders. Her research focuses on speech motor control in healthy talkers and those with neuromotor speech impairment; she applies this empirical evidence to the design of technologies that enable, enrich, and enhance communication. To address these interdisciplinary topics, she founded and directs the Communication Analysis and Design Laboratory, the Center of Speech Science and Technology, and the doctoral program in Personal Health Informatics.

She has 60+ peer-reviewed journal articles, has presented at several hundred national and international conferences, and has garnered over $5M in research funding from the National Institutes of Health, the National Science Foundation and private foundations. She also holds appointments in the Harvard/MIT Speech and Hearing Biosciences and Technology program, the Department of Psychiatry at University of Massachusetts, and Haskins Laboratory at Yale University. She earned her bachelor’s degree from the University of Calgary, her master’s and PhD from the University of Toronto, and she completed her post-doctoral training at MIT. She is a Fellow of the second class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

The complete list of the Health Innovator Fellows are:

  • Sonia Angell, Deputy Commissioner, NYC Department of Health and Mental Hygiene, New York, NY
  • Piraye Beim, Founder and CEO, Celmatix, New York, NY
  • Cybele Bjorklund, Head of Policy, Sanofi, Washington, DC
  • Dipal Doshi, Chief Business Officer, Amicus Therapeutics, Inc., Princeton, NJ
  • Amy Duross, Managing Director, GE Ventures, Healthcare Incubations, Menlo Park, CA
  • Wayne Franklin, Director and Founder, Texas Adult Congenital Heart Program, Texas Children’s Hospital Heart Center, Houston, TX
  • Nadine Gracia, Deputy Assistant Secretary and Director of the Office of Minority Health, U.S. Department of Health and Human Services, Washington, DC
  • Michael Howell, Chief Quality Officer, University of Chicago Medicine, Chicago, IL
  • David Hutchings, Vice President of Therapy, Amedisys Home Health and Hospice Care, Spring Hill, TN
  • Sachin Jain, CEO, CareMore, Los Angeles, CA
  • Anthony Johnson, President and CEO, Empire Genomics, LLC, Buffalo, NY
  • Megan Jones Bell, Chief Science Officer, Founding Executive Team, Lantern; Consulting Assistant Professor, Stanford University; Palo Alto, CA
  • Catherine Kenworthy, President and CEO, Interactive Health, Chicago, IL
  • Margaret Lapiz, Executive Vice President, the Permanente Medical Group, Kaiser Permanente, Oakland, CA
  • Stacy Lindau, Associate Professor, University of Chicago; Founder and Chief Innovation Officer, NowPow, LLC; Chicago, IL
  • Rupal Patel, Founder and President, VocaliD, Inc., Boston, MA
  • Wizdom Powell, Associate Professor of Health Behavior, University of North Carolina, Gillings School of Public Health, Chapel Hill, NC
  • Ricardo Rivera-Cardona, Executive Director, Puerto Rico Health Insurance Administration, San Juan, Puerto Rico
  • David Roberts, Dean for External Education, Harvard Medical School, Boston, MA
  • Kyle Rolfing, Founder and President, Bright Health, Minneapolis, MN
  • Elsie Taveras, Chief, General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, MA.

Leave a Comment

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.